Barclays’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Sell |
996
-5,769
| -85% | -$11.6K | ﹤0.01% | 4281 |
|
|
2025
Q1 | $29K | Sell |
6,765
-1,976
| -23% | -$8.47K | ﹤0.01% | 4008 |
|
|
2024
Q4 | $75K | Buy |
8,741
+8,718
| +37,904% | +$74.8K | ﹤0.01% | 3856 |
|
|
2024
Q3 | $0 | Buy |
23
+18
| +360% | – | ﹤0.01% | 4485 |
|
|
2024
Q2 | $0 | Sell |
5
-811
| -99% | – | ﹤0.01% | 4358 |
|
|
2024
Q1 | $13K | Sell |
816
-1,628
| -67% | -$25.9K | ﹤0.01% | 3987 |
|
|
2023
Q4 | $38K | Sell |
2,444
-5,368
| -69% | -$83.5K | ﹤0.01% | 3882 |
|
|
2023
Q3 | $595K | Buy |
7,812
+425
| +6% | +$32.4K | ﹤0.01% | 2430 |
|
|
2023
Q2 | $484K | Buy |
7,387
+194
| +3% | +$12.7K | ﹤0.01% | 2618 |
|
|
2023
Q1 | $430K | Hold |
7,193
| – | – | ﹤0.01% | 2739 |
|
|
2022
Q4 | $168K | Hold |
7,193
| – | – | ﹤0.01% | 3191 |
|
|
2022
Q3 | $241K | Buy |
7,193
+1,798
| +33% | +$60.2K | ﹤0.01% | 2983 |
|
|
2022
Q2 | $143K | Buy |
5,395
+5,039
| +1,415% | +$134K | ﹤0.01% | 3300 |
|
|
2022
Q1 | $10K | Buy |
+356
| New | +$10K | ﹤0.01% | 4489 |
|